Critical Ill Patients
5
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 5 trials
100.0%
+13.5% vs benchmark
20%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Glycated Hbg Index and RDW as Prognstic Indicator in Critical Ill Patients
Different Dosing Strategies of Colistin in Multidrug-Resistant Gram-Negative Bacilli Infections
Efficacy and Safety of Heparin-coated Surface-treated Polyacrylonitrile Membrane Hemofilter in Critical Ill CRRT Patients
Looking at the Physiological Response of Ergometry in Critical Care Patients
Closed-loop Versus Conventional Ventilation Mode During Mobilization Period in Critical Care Patients